HIGHLIGHTS
- who: Martin Panigaj et al. from the University of Cambridge, United Kingdom have published the Article: Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles, in the Journal: (JOURNAL)
- what: This approach has been tested in a murine model and was found to outperform the administration of an agonistic 4-1BB Ab or 4-1BB aptamer alone .
- future: This review highlights several recent advances and possible future directions of TNA and NANP technologies that are under development for controlled Addition of cryoprotectants such as trehalose seemed to aid in reducing the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.